These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
555 related articles for article (PubMed ID: 11151398)
1. Cost analysis of an adult outpatient parenteral antibiotic therapy (OPAT) programme. A Canadian teaching hospital and Ministry of Health perspective. Wai AO; Frighetto L; Marra CA; Chan E; Jewesson PJ Pharmacoeconomics; 2000 Nov; 18(5):451-7. PubMed ID: 11151398 [TBL] [Abstract][Full Text] [Related]
2. A cost analysis of Outpatient Parenteral Antibiotic Therapy (OPAT): an Asian perspective. Yong C; Fisher DA; Sklar GE; Li SC Int J Antimicrob Agents; 2009 Jan; 33(1):46-51. PubMed ID: 18823759 [TBL] [Abstract][Full Text] [Related]
3. Clinical efficacy, cost analysis and patient acceptability of outpatient parenteral antibiotic therapy (OPAT): a decade of Sheffield (UK) OPAT service. Durojaiye OC; Bell H; Andrews D; Ntziora F; Cartwright K Int J Antimicrob Agents; 2018 Jan; 51(1):26-32. PubMed ID: 28673610 [TBL] [Abstract][Full Text] [Related]
4. Outpatient parenteral antibiotic therapy in Singapore. Fisher DA; Kurup A; Lye D; Tambyah PA; Sulaiman Z; Poon EY; Lee W; Kaur V; Lim PL Int J Antimicrob Agents; 2006 Dec; 28(6):545-50. PubMed ID: 17097856 [TBL] [Abstract][Full Text] [Related]
5. Acute dental infections managed in an outpatient parenteral antibiotic program setting: prospective analysis and public health implications. Connors WJ; Rabie HH; Figueiredo RL; Holton DL; Parkins MD BMC Infect Dis; 2017 Mar; 17(1):202. PubMed ID: 28279155 [TBL] [Abstract][Full Text] [Related]
6. Willingness to pay to assess patient preferences for therapy in a Canadian setting. Marra CA; Frighetto L; Goodfellow AF; Wai AO; Chase ML; Nicol RE; Leong CA; Tomlinson S; Ferreira BM; Jewesson PJ BMC Health Serv Res; 2005 Jun; 5():43. PubMed ID: 15941474 [TBL] [Abstract][Full Text] [Related]
7. Costs of outpatient parenteral antimicrobial therapy (OPAT) administered by Hospital at Home units in Spain. González-Ramallo VJ; Mirón-Rubio M; Mujal A; Estrada O; Forné C; Aragón B; Rivera AJ Int J Antimicrob Agents; 2017 Jul; 50(1):114-118. PubMed ID: 28499957 [TBL] [Abstract][Full Text] [Related]
8. Cost-utility analysis of outpatient parenteral antimicrobial therapy (OPAT) in the Brazilian national health system. Psaltikidis EM; Silva END; Moretti ML; Trabasso P; Stucchi RSB; Aoki FH; Cardoso LGO; Höfling CC; Bachur LF; Ponchet DDF; Colombrini MRC; Tozzi CS; Ramos RF; Costa SMQ; Resende MR Expert Rev Pharmacoecon Outcomes Res; 2019 Jun; 19(3):341-352. PubMed ID: 30362845 [TBL] [Abstract][Full Text] [Related]
9. Outpatient parenteral antimicrobial therapy (OPAT) in a teaching hospital-based practice: a retrospective cohort study describing experience and evolution over 10 years. Barr DA; Semple L; Seaton RA Int J Antimicrob Agents; 2012 May; 39(5):407-13. PubMed ID: 22445493 [TBL] [Abstract][Full Text] [Related]
10. Economic Burden of Home Antimicrobial Therapy: OPAT Versus Oral Therapy. Krah NM; Bardsley T; Nelson R; Esquibel L; Crosby M; Byington CL; Pavia AT; Hersh AL Hosp Pediatr; 2019 Apr; 9(4):234-240. PubMed ID: 30885919 [TBL] [Abstract][Full Text] [Related]
11. Clinical efficacy and cost-effectiveness of outpatient parenteral antibiotic therapy (OPAT): a UK perspective. Chapman AL; Dixon S; Andrews D; Lillie PJ; Bazaz R; Patchett JD J Antimicrob Chemother; 2009 Dec; 64(6):1316-24. PubMed ID: 19767623 [TBL] [Abstract][Full Text] [Related]
12. Impact of the implementation of a nurse-managed outpatient parenteral antibiotic therapy (OPAT) system in Baltimore: a case study demonstrating cost savings and reduction in re-admission rates. Mansour O; Heslin J; Townsend JL J Antimicrob Chemother; 2018 Nov; 73(11):3181-3188. PubMed ID: 30085088 [TBL] [Abstract][Full Text] [Related]
13. Mandatory infectious diseases approval of outpatient parenteral antimicrobial therapy (OPAT): clinical and economic outcomes of averted cases. Conant MM; Erdman SM; Osterholzer D J Antimicrob Chemother; 2014 Jun; 69(6):1695-700. PubMed ID: 24532684 [TBL] [Abstract][Full Text] [Related]
15. Association of laboratory test result availability and rehospitalizations in an outpatient parenteral antimicrobial therapy programme. Huck D; Ginsberg JP; Gordon SM; Nowacki AS; Rehm SJ; Shrestha NK J Antimicrob Chemother; 2014 Jan; 69(1):228-33. PubMed ID: 23887864 [TBL] [Abstract][Full Text] [Related]
16. The use, appropriateness and outcomes of outpatient parenteral antimicrobial therapy. Hodgson KA; Huynh J; Ibrahim LF; Sacks B; Golshevsky D; Layley M; Spagnolo M; Raymundo CM; Bryant PA Arch Dis Child; 2016 Oct; 101(10):886-93. PubMed ID: 27166221 [TBL] [Abstract][Full Text] [Related]
17. Self-Administered Outpatient Antimicrobial Infusion by Uninsured Patients Discharged from a Safety-Net Hospital: A Propensity-Score-Balanced Retrospective Cohort Study. Bhavan KP; Brown LS; Haley RW PLoS Med; 2015 Dec; 12(12):e1001922. PubMed ID: 26671467 [TBL] [Abstract][Full Text] [Related]
18. Supervised self-administration of outpatient parenteral antibiotic therapy: a report from a large tertiary hospital in Australia. Subedi S; Looke DF; McDougall DA; Sehu MM; Playford EG Int J Infect Dis; 2015 Jan; 30():161-5. PubMed ID: 25603999 [TBL] [Abstract][Full Text] [Related]